{"id":1345,"date":"2016-02-29T14:14:16","date_gmt":"2016-02-29T13:14:16","guid":{"rendered":"https:\/\/ngm-cancer.com\/en\/?page_id=1345"},"modified":"2016-03-07T12:04:26","modified_gmt":"2016-03-07T11:04:26","slug":"fast-track-analysis-for-first-line-treatment","status":"publish","type":"page","link":"https:\/\/ngm-cancer.com\/en\/fast-track-analysis-for-first-line-treatment\/","title":{"rendered":"Fast-track analysis for first-line treatment"},"content":{"rendered":"

[et_pb_section admin_label=”Sektion” global_module=”1228″ fullwidth=”on” specialty=”off” transparent_background=”off” allow_player_pause=”off” inner_shadow=”off” parallax=”off” parallax_method=”off” padding_mobile=”off” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off”][et_pb_fullwidth_slider global_parent=”1228″ admin_label=”Vollbreiter Slider” show_arrows=”on” show_pagination=”on” auto=”off” auto_ignore_hover=”off” parallax=”off” parallax_method=”off” remove_inner_shadow=”off” background_position=”default” background_size=”default” hide_content_on_mobile=”off” hide_cta_on_mobile=”off” show_image_video_mobile=”off” custom_button=”off” button_border_radius=”0″ button_letter_spacing=”0″ button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on” button_border_radius_hover=”0″ button_letter_spacing_hover=”0″ custom_css_main_element=”height:350px;” custom_css_slide_description=”height:350px;”]<\/p>\n

[et_pb_slide background_image=”https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/291_1920x400_iStock_000079390049_Double.jpg” background_position=”default” background_size=”default” background_color=”#ffffff” use_bg_overlay=”off” use_text_overlay=”off” alignment=”center” background_layout=”dark” allow_player_pause=”off” text_border_radius=”3″ header_font_select=”default” header_font=”||||” body_font_select=”default” body_font=”||||” custom_button=”off” button_font_select=”default” button_font=”||||” button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on”] [\/et_pb_slide][et_pb_slide background_image=”https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/291_1920x400_iStock_000072362727_XXXLarge.jpg” background_position=”default” background_size=”default” background_color=”#ffffff” use_bg_overlay=”off” use_text_overlay=”off” alignment=”center” background_layout=”dark” allow_player_pause=”off” text_border_radius=”3″ header_font_select=”default” header_font=”||||” body_font_select=”default” body_font=”||||” custom_button=”off” button_font_select=”default” button_font=”||||” button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on”] [\/et_pb_slide][et_pb_slide background_image=”https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/291_1920x400_iStock_000085082221_Full.jpg” background_position=”default” background_size=”default” background_color=”#ffffff” use_bg_overlay=”off” use_text_overlay=”off” alignment=”center” background_layout=”dark” allow_player_pause=”off” text_border_radius=”3″ header_font_select=”default” header_font=”||||” body_font_select=”default” body_font=”||||” custom_button=”off” button_font_select=”default” button_font=”||||” button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on”] [\/et_pb_slide][et_pb_slide background_image=”https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/291_1920x400_iStock_000069171885_Full.jpg” background_position=”default” background_size=”default” background_color=”#ffffff” use_bg_overlay=”off” use_text_overlay=”off” alignment=”center” background_layout=”dark” allow_player_pause=”off” text_border_radius=”3″ header_font_select=”default” header_font=”||||” body_font_select=”default” body_font=”||||” custom_button=”off” button_font_select=”default” button_font=”||||” button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on”] [\/et_pb_slide]<\/p>\n

[\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section admin_label=”Sektion” fullwidth=”off” specialty=”on”][et_pb_column type=”3_4″ specialty_columns=”3″][et_pb_row_inner admin_label=”Zeile”][et_pb_column_inner type=”4_4″ saved_specialty_column_type=”3_4″][et_pb_post_title admin_label=”Posttitel” title=”on” meta=”off” author=”on” date=”on” categories=”on” comments=”on” featured_image=”off” featured_placement=”below” parallax_effect=”on” parallax_method=”on” text_orientation=”left” text_color=”dark” text_background=”off” text_bg_color=”rgba(255,255,255,0.9)” module_bg_color=”rgba(255,255,255,0)” title_all_caps=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]<\/p>\n

[\/et_pb_post_title][et_pb_text admin_label=”Text” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]<\/p>\n

\n\t\t\t\t\tFrequently, a very rapid decision for a first-line treatment is necessary after the diagnosis of lung cancer. To bring our philosophy of a comprehensive, best possible molecular diagnostics into line with the need for rapid decision-making for a potential molecular therapy, since early 2015, and in addition to the comprehensive diagnostics by multiplex PCR or hybrid capture sequencing<\/a>, we carry out a so-called Fast-Track Analysis for individual parameters which are very important for the first-line treatment (EGFR, ALK, KRAS, possibly also ROS1). Requesting physician are provided with these parameters within 4 working days in advance.\n\t\t\t\t<\/div>
\n\t\t\t\t\t\"Netzwerk\n\t\t\t\t<\/div>
<\/div><\/p>\n

[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=”Zeile”][et_pb_column_inner type=”4_4″ saved_specialty_column_type=”3_4″][et_pb_text admin_label=”Last Update” global_module=”1340″ saved_tabs=”all” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid” module_class=”content-update”]<\/p>\n

Last update: 07. March 2016 , 12:04<\/span><\/em><\/p>\n

[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=”1_4″][et_pb_sidebar admin_label=”Seitenleiste” orientation=”right” area=”et_pb_widget_area_5″ background_layout=”light” remove_border=”off”]<\/p>\n

[\/et_pb_sidebar][\/et_pb_column][\/et_pb_section][et_pb_section admin_label=”section” global_module=”1336″ fullwidth=”off” transparent_background=”off” background_color=”#eeeeee” allow_player_pause=”off” inner_shadow=”off” parallax=”on” parallax_method=”on” padding_mobile=”off” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off” gutter_width=”3″ background_image=”https:\/\/ngm-cancer.com\/wp-content\/uploads\/2015\/12\/291_ngm_BG-t5.png”][et_pb_row global_parent=”1336″ admin_label=”row” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” use_custom_gutter=”off” gutter_width=”3″ padding_mobile=”off” allow_player_pause=”off” parallax=”off” parallax_method=”on” make_equal=”on” parallax_1=”off” parallax_method_1=”off” background_color_1=”#ffffff” padding_top_1=”50px” padding_right_1=”32px” padding_bottom_1=”50px” padding_left_1=”32px” parallax_2=”off” parallax_method_2=”off” background_color_2=”#ffffff” padding_top_2=”50px” padding_right_2=”32px” padding_bottom_2=”50px” padding_left_2=”32px” parallax_3=”off” parallax_method_3=”off” background_color_3=”#ffffff” padding_top_3=”50px” padding_right_3=”32px” padding_bottom_3=”50px” padding_left_3=”32px” column_padding_mobile=”on” module_id=”pseudofooter-row”][et_pb_column type=”1_3″][et_pb_blurb global_parent=”1336″ admin_label=”Molekulare Diagnostik” title=”Molecular diagnostics” url_new_window=”off” animation=”off” background_layout=”light” text_orientation=”center” icon_placement=”top” font_icon=”%%103%%” use_icon=”on” use_circle=”off” use_circle_border=”off” icon_color=”#3b78aa” circle_color=”#81d742″ circle_border_color=”#2caaca” url=”\/?p=74\/” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” header_line_height=”1.5em”]<\/p>\n

As the first group in Europe, the Network Genomic Medicine has offered a comprehensive analysis of tumor material since 2012. By means of a multiplex-test in combination with highly sensitive deep sequencing even rare gene mutations in the smallest tissue samples are detected reliably<\/p>\n

[\/et_pb_blurb][et_pb_divider global_parent=”1336″ admin_label=”Teiler” color=”#ffffff” show_divider=”off” divider_style=”solid” divider_position=”top” hide_on_mobile=”on” height=”2″]<\/p>\n

[\/et_pb_divider][et_pb_cta global_parent=”1336″ admin_label=”Diagnostik” button_url=”https:\/\/ngm-cancer.com\/en\/diagnostics\/” url_new_window=”off” button_text=”Diagnostics” use_background_color=”off” background_color=”#4d9acf” background_layout=”light” text_orientation=”center” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_button=”off” button_text_size=”16″ button_border_radius=”0″ button_letter_spacing=”0″ button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on” button_border_radius_hover=”0″ button_letter_spacing_hover=”0″]<\/p>\n

[\/et_pb_cta][\/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb global_parent=”1336″ admin_label=”Second opinion” title=”Second opinion” url_new_window=”off” animation=”off” background_layout=”light” text_orientation=”center” icon_placement=”top” font_icon=”%%86%%” use_icon=”on” use_circle=”off” use_circle_border=”off” icon_color=”#3b78aa” circle_color=”#999999″ circle_border_color=”#2caaca” url=”\/?p=76\/” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” header_line_height=”1.5em”]<\/p>\n

Do you have questions about your disease or your current therapy? Or maybe you would like to know if for you a personalized treatment approach or immunotherapy might be considered. Please feel free to contact us!<\/p>\n

[\/et_pb_blurb][et_pb_divider global_parent=”1336″ admin_label=”Teiler” color=”#ffffff” show_divider=”off” height=”53″ divider_style=”solid” divider_position=”top” hide_on_mobile=”on”]<\/p>\n

[\/et_pb_divider][et_pb_cta global_parent=”1336″ admin_label=”Zweitmeinung” button_url=”https:\/\/ngm-cancer.com\/en\/second-opinion-service\/” url_new_window=”off” button_text=”Second Opinion” use_background_color=”off” background_color=”#4d9acf” background_layout=”light” text_orientation=”center” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_button=”off” button_text_size=”16″ button_border_radius=”0″ button_letter_spacing=”0″ button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on” button_border_radius_hover=”0″ button_letter_spacing_hover=”0″]<\/p>\n

[\/et_pb_cta][\/et_pb_column][et_pb_column type=”1_3″][et_pb_blurb global_parent=”1336″ admin_label=”Clinical trials” title=”Clinical trials” url_new_window=”off” animation=”off” background_layout=”light” text_orientation=”center” icon_placement=”top” font_icon=”%%77%%” use_icon=”on” use_circle=”off” use_circle_border=”off” icon_color=”#3b78aa” circle_color=”#81d742″ circle_border_color=”#2caaca” url=”\/?p=76\/” use_icon_font_size=”off” use_border_color=”off” border_color=”#ffffff” border_style=”solid” header_line_height=”1.5em”]<\/p>\n

At the Network Genomic Medicine we try to offer an appropriate clinical trial testing a new drug to all our patients who have a detected mutation, for which there has no drug been approved for treatment yet. For that we work closely together with the Lung Cancer Group Cologne.<\/p>\n

[\/et_pb_blurb][et_pb_divider global_parent=”1336″ admin_label=”Teiler” color=”#ffffff” show_divider=”off” height=”2″ divider_style=”solid” divider_position=”top” hide_on_mobile=”on”]<\/p>\n

[\/et_pb_divider][et_pb_cta global_parent=”1336″ admin_label=”Studien” button_url=”https:\/\/ngm-cancer.com\/en\/clinical-trials\/” url_new_window=”off” button_text=”Trials” use_background_color=”off” background_color=”#4d9acf” background_layout=”light” text_orientation=”center” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_button=”off” button_text_size=”16″ button_border_radius=”0″ button_letter_spacing=”0″ button_use_icon=”default” button_icon_placement=”right” button_on_hover=”on” button_border_radius_hover=”0″ button_letter_spacing_hover=”0″]<\/p>\n

[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

\n\t\t\t\t\t\n\t\t\t\t<\/div>Frequently, a very rapid decision for a first-line treatment is necessary after the diagnosis of lung cancer. To bring our philosophy of a comprehensive, best possible molecular diagnostics into line with the need for rapid decision-making for a potential molecular therapy, since early 2015, and in addition to the comprehensive diagnostics by multiplex PCR or […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":0,"menu_order":8,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"kontext":[],"_links":{"self":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1345"}],"collection":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/comments?post=1345"}],"version-history":[{"count":1,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1345\/revisions"}],"predecessor-version":[{"id":1347,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1345\/revisions\/1347"}],"wp:attachment":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/media?parent=1345"}],"wp:term":[{"taxonomy":"kontext","embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/kontext?post=1345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}